Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for acute and chronic pain. Its lead candidate, SP-102 (10 mg dexamethasone sodium phosphate viscous gel), targets moderate to severe lumbar radicular pain (sciatica) via epidural steroid injection, has received FDA Fast Track designation, and completed a pivotal Phase 3 study with positive primary and secondary endpoints published in PAIN Journal in June 2024.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001193125-26-082642 | EDGAR | 110K words |
| 2025-04-02 | 2024-12-31 | 0001213900-25-027319 | EDGAR | 48K words |
| 2024-04-01 | 2023-12-31 | 0001213900-24-028809 | EDGAR | 41K words |
| 2023-03-17 | 2022-12-31 | 0001575872-23-000375 | EDGAR | 35K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001193125-26-342594 | EDGAR | 75K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277536 | EDGAR | 78K words |
| 2025-08-15 | 2025-06-30 | 0001213900-25-077047 | EDGAR | 29K words |
| 2025-05-16 | 2025-03-31 | 0001213900-25-044889 | EDGAR | 27K words |
| 2024-11-19 | 2024-09-30 | 0001213900-24-100217 | EDGAR | 28K words |
| 2024-08-19 | 2024-06-30 | 0001213900-24-070799 | EDGAR | 24K words |
| 2024-05-22 | 2024-03-31 | 0001213900-24-045702 | EDGAR | 23K words |
| 2023-11-09 | 2023-09-30 | 0001213900-23-085292 | EDGAR | 26K words |
| 2023-08-15 | 2023-06-30 | 0001213900-23-067759 | EDGAR | 24K words |
| 2023-05-15 | 2023-03-31 | 0001575872-23-000755 | EDGAR | 19K words |
| 2022-11-16 | 2022-09-30 | 0001575872-22-001134 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001575872-22-000781 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-17 | 0001193125-26-110816 | EDGAR | 4K words |
| 2025-12-03 | 0001193125-25-306757 | EDGAR | 8K words |
| 2025-09-26 | 0001193125-25-220455 | EDGAR | 10K words |
| 2025-09-04 | 0001213900-25-084180 | EDGAR | 2K words |
| 2025-08-22 | 0001213900-25-079504 | EDGAR | 15K words |
| 2025-08-11 | 0001213900-25-073907 | EDGAR | 1K words |
| 2025-07-28 | 0001213900-25-068263 | EDGAR | 2K words |
| 2025-07-11 | 0001213900-25-063294 | EDGAR | 1K words |
| 2025-06-12 | 0001213900-25-053576 | EDGAR | 1K words |
| 2025-05-12 | 0001213900-25-041653 | EDGAR | 1K words |
69 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001913577 |
| Ticker | SMNR |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SMNR (~200 tokens, structured JSON with cryptographic provenance)